Related Experiment Video
Updated: Jun 13, 2026
05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
[Time-effect study of propylthiouracil-induced thyroid gland hyperplasia]
Yu Wang1, Sucai Zhang, Weibo Cheng
1Department of Pathology, School of Public Health, Sichuan University, Chengdu 610041, China.
Wei Sheng Yan Jiu = Journal of Hygiene Research
|March 10, 2009
Summary
This study developed a short-term method to detect thyroid hormone disruptors in rats. Six days of exposure revealed significant changes, indicating this timeframe is optimal for identifying thyroid disruptors.
Area of Science:
- Endocrinology
- Toxicology
- Biomarker Discovery
Context:
- Thyroid hormone disruptors pose a significant public health concern.
- Standardized methods for evaluating these disruptors are crucial for risk assessment.
- Existing methods may lack the sensitivity or speed for rapid in vivo assessment.
Purpose:
- To establish an effective, short-time, standardized in vivo system for discriminating thyroid hormone disruptors.
- To identify reliable biomarkers for early detection of thyroid gland disruption.
Summary:
- Rats were treated with propylthiouracil (PTU) for 3, 6, 9, or 12 days, with a control group.
- Serum thyroid hormones (T3, T4, TSH), thyroid gland histopathology, colloid changes (PAS staining), and cell proliferation (PCNA) were analyzed.
- Significant decreases in TT3 and TT4, increased TSH, thyroid gland enlargement, hyperplasia, and altered colloid were observed, with PCNA index peaking at 6 days.
Impact:
- The study identified hyperplastic patches, solid bubbles, and PCNA labeling index as stable and reliable early indicators of thyroid gland hyperplasia.
- The findings suggest that a 6-day experimental phase is optimal for detecting thyroid disruptor effects.
- This method provides a foundation for a rapid and standardized in vivo screening system for thyroid hormone disruptors.
Related Concept Videos
01:20Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
01:18Functions of Thyroid Hormones
The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:27Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...